Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Sirniö, P. (Päivi)"'
Autor:
Sirniö, P. (Päivi)
Colorectal cancer (CRC) is the third most common cancer and the second leading cause of cancer-related deaths worldwide. In some CRC patients, the presence of the tumor elicits a systemic inflammatory response and metabolic derangements that lead to
Externí odkaz:
http://urn.fi/urn:isbn:9789526224022
Autor:
Sirniö, P. (Päivi), Väyrynen, J. P. (Juha P.), Mutt, S. J. (Shivaprakash J.), Herzig, K.-H. (Karl-Heinz), Walkowiak, J. (Jaroslaw), Klintrup, K. (Kai), Mäkelä, J. (Jyrki), Karttunen, T. J. (Tuomo J.), Mäkinen, M. J. (Markus J.), Tuomisto, A. (Anne)
Systemic inflammation is a stage-independent marker of poor prognosis in colorectal cancer (CRC), activated in a complex, multifactorial process. It has been proposed that one of the main factors driving systemic inflammation may be tumor necrosis. K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2423::b644fa729c521f369386f253062f8452
http://urn.fi/urn:nbn:fi-fe2020082864577
http://urn.fi/urn:nbn:fi-fe2020082864577
Autor:
Sirniö, P. (Päivi), Väyrynen, J. P. (Juha P.), Klintrup, K. (Kai), Mäkelä, J. (Jyrki), Karhu, T. (Toni), Herzig, K.-H. (Karl-Heinz), Minkkinen, I. (Ilkka), Mäkinen, M. J. (Markus J.), Karttunen, T. J. (Tuomo J.), Tuomisto, A. (Anne)
Background: Cancer cachexia is a complex wasting syndrome affecting patients with advanced cancer, with systemic inflammation as a key component in pathogenesis. Protein degradation and release of amino acids (AAs) in skeletal muscle are stimulated i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2423::b6a478873e91701ebf2396ead2a1ded0
http://urn.fi/urn:nbn:fi-fe202002216172
http://urn.fi/urn:nbn:fi-fe202002216172
Autor:
Tuomisto, A. (Anne), Nørskov, N. P. (Natalja P.), Sirniö, P. (Päivi), Väyrynen, J. P. (Juha P.), Mutt, S. J. (Shivaprakash J.), Klintrup, K. (Kai), Mäkelä, J. (Jyrki), Knudsen, K. E. (Knud Erik Bach), Mäkinen, M. J. (Markus J.), Herzig, K.-H. (Karl-Heinz)
The dietary lignan metabolite, enterolactone, has been suggested to have anti-cancer functions, and high serum enterolactone concentrations have been associated with decreased risk of breast and prostate cancers. We hypothesized that serum enterolact
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2423::3fc77c75df689f40561401a643265cd9
http://urn.fi/urn:nbn:fi-fe2019082024792
http://urn.fi/urn:nbn:fi-fe2019082024792